Malignant Duodenal Neoplasm — Trials

Malignant Duodenal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 18
Recruiting: 13
Ph III recruiting: 3
Growth YoY: —
Industry share: 0%
Top sponsor: Minia University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06690281	A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies	withdrawn	Phase 2	0	National Cancer Institute (NCI)NIH	1	Sep 11, 2025	clinicaltrials

Data updated 22 days agoSource updated Sep 11, 2025source: clinicaltrials